Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

ALERCHEK OPHTHALMIC SOLUTION 0.1% [SIN15527P]

Active ingredients: OLOPATADINE HYDROCHLORIDE 1.11 MG/ML EQV OLOPATADINE

View product's general information
Last updated 16 September 2026

Product Info

ALERCHEK OPHTHALMIC SOLUTION 0.1%

[SIN15527P]

Product information

Active Ingredient and Strength

OLOPATADINE HYDROCHLORIDE 1.11 MG/ML EQV OLOPATADINE - 1 MG/ML

Dosage Form

SOLUTION, STERILE

Manufacturer and Country

INDOCO REMEDIES LIMITED - INDIA

Registration Number

SIN15527P

Licence Holder

GOLDPLUS UNIVERSAL PTE LTD

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

S01GX09

Prescription-only Medicines with Exemptions for Supply without Prescription

As an eyedrop not exceeding 0.2%

  • Indication: Short-term treatment of symptoms of allergic conjunctivitis

  • Maximum daily dose:

  • 0.1%: One drop in each affected eye two times per day

  • 0.2%: One drop in each affected eye once a day

  • Maximum supply:

  • 0.1%: 5ml

  • 0.2%: 2.5ml

  • Minimum age: 3 years

Indication

INDICATIONS
ALERCHEK 0.1% (olopatadine hydrochloride ophthalmic solution 0.1%) is indicated for the treatment of the signs and symptoms of allergic conjunctivitis.

Dosing

DOSAGE AND ADMINISTRATION
Dosage
The recommended dose is 1 drop in each affected eye 2 times per day.

Use in children
Safety and effectiveness in paediatric patients below the age of 3 years have not been established.

Use in patients with hepatic or renal impairment
No clinical studies with ALERCHEK 0.1% eye drops have been conducted in patients with renal or hepatic impairment; therefore the efficacy and safety of ALERCHEK 0.1% eye drops in these patients have yet to be established.

Method of administration
For ocular use.
After cap is removed, if tamper evident snap collar is loose, remove before using product.
To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas or other surfaces with the dropper tip. Keep the bottle tightly closed when not in use.
Nasolacrimal occlusion or gently closing the eyelid after administration is recommended. This may reduce the systemic absorption of medicinal products administered via the ocular route and result in a decrease in systemic adverse reactions.
If more than one topical ophthalmic product is being used, the products must be administered at least 5 minutes apart. Eye ointments should be administered last.

Contraindications

CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients.